Oxytetracycline
Indications: - Other specified conjunctivitis - Infectious keratitis - Trachoma - Infectious blepharitis Source: EML workbook import

Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
Indications: - Other specified conjunctivitis - Infectious keratitis - Trachoma - Infectious blepharitis Source: EML workbook import
Formulations: - Local > Ophthalmological > Ointment: 1% (tetracycline hydrochloride) Indications: - Neonatal conjunctivitis or dacryocystitis - Other specified conjunctivitis - Infectious keratitis - Trachoma - Infectious blepharitis Source: EML workbook import
Indications: - Other specified conjunctivitis - Infectious blepharitis Source: EML workbook import
Formulations: - Parenteral > Locoregional injections > Intravitreal: 25 mg per mL Indications: - Age related macular degeneration Source: EML workbook import
Formulations: - Local > Ophthalmological > Solution (eye drops): 0.5% (hydrochloride) Indications: - Local anaesthetics Source: EML workbook import
Formulations: - Oral > Solid: 250 mg Indications: - Primary open-angle glaucoma Source: EML workbook import
Indications: - Acute angle closure with pupillary block - Ocular hypertension - Primary open-angle glaucoma Source: EML workbook import
Formulations: - Local > Ophthalmological > Solution (eye drops): 50 µg per mL eye drops Indications: - Primary open-angle glaucoma Source: EML workbook import
Formulations: - Local > Ophthalmological > Solution (eye drops): 2% (hydrochloride or nitrate); 4% (hydrochloride or nitrate) Indications: - Acute angle closure with pupillary block - Ocular hypertension - Primary open-angle glaucoma Source: EML workbook import
Formulations: - Local > Ophthalmological > Solution (eye drops): 0.25% (hydrogen maleate); 0.5% (hydrogen maleate) Indications: - Ocular hypertension - Primary open-angle glaucoma Source: EML workbook import
Formulations: - Local > Ophthalmological > Solution (eye drops): 2% (hydrobromide) Indications: - Anterior uveitis Source: EML workbook import
Formulations: - Local > Topical > Transdermal patch: 12 µg/hour; 25 µg/hour; 50 µg/hour; 75 µg/hour; 100 µg/hour Oral > Solid: 100 to 800 µg sub-lingual tablet (as citrate); 200 to 1600 µg lozenge (as citrate) Oral > Other: 200 to 1200 µg buccal film (as citrate) Indications: - Chronic cancer pain Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.